A roadmap for comparing readmission policies with application to Denmark, England, Germany and the United States

被引:125
作者
Kristensen, Soren Rud [1 ,2 ]
Bech, Mickael [2 ]
Quentin, Wilm [3 ,4 ]
机构
[1] Univ Manchester, Manchester Ctr Hlth Econ, Manchester M13 9PL, Lancs, England
[2] Univ Southern Denmark, Dept Econ & Business, COHERE Ctr Hlth Econ Res, Odense, Denmark
[3] Berlin Univ Technol, Dept Hlth Care Management, Berlin, Germany
[4] European Observ Hlth Syst & Policies, Brussels, Belgium
关键词
Hospital reimbursement; Readmission rates; Provider payment; Readmission policies; Avoidable readmissions; AVOIDABLE HOSPITAL READMISSIONS; PERFORMANCE DATA; MEDICARE READMISSIONS; PROSPECTIVE-PAYMENT; HEALTH-CARE; QUALITY; RATES; POPULATION;
D O I
10.1016/j.healthpol.2014.12.009
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Hospital readmissions receive increasing interest from policy makers because reducing unnecessary readmissions has the potential to simultaneously improve quality and save costs. This paper reviews readmission policies in Denmark, England, Germany and the United States (Medicare system). The suggested roadmap enables researchers and policy makers to systematically compare and analyse readmission policies. We find considerable differences across countries. In Germany, the readmission policy aims to avoid unintended consequences of the introduction of DRG-based payment; it focuses on readmissions of individual patients and hospitals receive only one DRG-based payment for both the initial and the re-admission. In Denmark, England and the US readmission policies aim at quality improvement and focus on readmission rates. In Denmark, readmission rates are publicly reported but payments are not adjusted in relation to readmissions. In England and the US, financial incentives penalise hospitals with readmission rates above a certain benchmark. In England, this benchmark is defined through local clinical review, while it is based on the risk-adjusted national average in the US. At present, not enough evidence exists to give recommendations on the optimal design of readmission policies. The roadmap can be a tool for systematically assessing how elements of other countries' readmission policies can potentially be adopted to improve national policies. (C) 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
引用
收藏
页码:264 / 273
页数:10
相关论文
共 49 条
  • [1] HOSPITAL READMISSIONS IN THE MEDICARE POPULATION
    ANDERSON, GF
    STEINBERG, EP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (21) : 1349 - 1353
  • [2] ANDERSON GF, 1985, INQUIRY-J HEALTH CAR, V22, P251
  • [3] *AUD COMM, 2008, RIGHT RES PAYM RES 2
  • [4] Barrett M., 2012, HCUP Methods Series Report #2012-04
  • [5] Medicare's Readmissions-Reduction Program - A Positive Alternative
    Berenson, Robert A.
    Paulus, Ronald A.
    Kalman, Noah S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15) : 1364 - 1366
  • [6] The Triple Aim: Care, health, and cost
    Berwick, Donald M.
    Nolan, Thomas W.
    Whittington, John
    [J]. HEALTH AFFAIRS, 2008, 27 (03) : 759 - 769
  • [7] BMGSS, 2003, AMTL BEGR REF KFPV 2
  • [8] Can all cause readmission policy improve quality or lower expenditures? A historical perspective on current initiatives
    Burgess, James F., Jr.
    Hockenberry, Jason M.
    [J]. HEALTH ECONOMICS POLICY AND LAW, 2014, 9 (02) : 193 - 213
  • [9] Busse R., 2011, Diagnosis-Related Groups in Europe
  • [10] Centers for Medicare and Medicaid Services (CMS) HHS, 2013, FED REGISTER, V78, P50495